Insider Transactions in Q3 2022 at Incyte Corp (INCY)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
250
+2.96%
|
$16,500
$66.64 P/Share
|
|
Sep 30
2022
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
291
+2.53%
|
$19,206
$66.64 P/Share
|
|
Sep 30
2022
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+2.97%
|
$22,374
$66.64 P/Share
|
|
Sep 30
2022
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
914
+0.01%
|
-
|
|
Jul 22
2022
|
Thomas Tray Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,564
-8.12%
|
$129,812
$83.13 P/Share
|
|
Jul 07
2022
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
5,787
-12.55%
|
$457,173
$79.38 P/Share
|
|
Jul 07
2022
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
2,873
-3.8%
|
$226,967
$79.38 P/Share
|
|
Jul 05
2022
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
987
-4.87%
|
$77,973
$79.25 P/Share
|
|
Jul 05
2022
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
2,599
-3.16%
|
$205,321
$79.25 P/Share
|
|
Jul 05
2022
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,856
-2.73%
|
$304,624
$79.25 P/Share
|
|
Jul 05
2022
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,124
-1.52%
|
$88,796
$79.25 P/Share
|
|
Jul 05
2022
|
Maria E Pasquale EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,043
-4.57%
|
$240,397
$79.25 P/Share
|
|
Jul 05
2022
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,599
-5.34%
|
$205,321
$79.25 P/Share
|
|
Jul 05
2022
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,174
-4.96%
|
$1,672,746
$79.25 P/Share
|
|
Jul 05
2022
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
3,506
-4.44%
|
$276,974
$79.25 P/Share
|
|
Jul 05
2022
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-4.08%
|
$172,299
$79.25 P/Share
|
|
Jul 02
2022
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+17.0%
|
-
|
|
Jul 02
2022
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
9,921
+10.76%
|
-
|
|
Jul 02
2022
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,941
+11.82%
|
-
|
|
Jul 02
2022
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,317
+19.01%
|
-
|
|
Jul 02
2022
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
13,529
+16.89%
|
-
|
|
Jul 02
2022
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
9,921
+16.92%
|
-
|
|
Jul 02
2022
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
60,433
+12.4%
|
-
|
|
Jul 02
2022
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
13,529
+14.61%
|
-
|
|
Jul 02
2022
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,274
+17.43%
|
-
|